Highbridge Capital Management’s ImmunoCellular Therapeutics, Ltd. IMUC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2013
Q4
Sell
-3,096
Closed -$318K 1223
2013
Q3
$318K Buy
+3,096
New +$318K ﹤0.01% 767